Endoplasmic reticulum stress, the unfolded protein response, and gene network modeling in antiestrogen resistant

Robert Clarke1, Ayesha N Shajahan, Yue Wang

  • 1Department of Oncology, Georgetown University School of Medicine, Washington, DC 20057, U.S.A. ; Lombardi Comprehensive Cancer Center, Georgetown University School of Medicine, Washington, DC 20057, U.S.A.

Insights

Systems biology offers new insights into endocrine resistance in breast cancer. Network modeling of the unfolded protein response (UPR) reveals key gene interactions, advancing understanding beyond reductionist approaches.

Area of Science:

  • Oncology
  • Systems Biology
  • Molecular Biology

Background:

  • Endocrine resistance in breast cancer poses a significant challenge, with current reductionist methods yielding limited progress.
  • Systems biology approaches offer a novel framework for understanding complex molecular signaling networks driving resistance.

Purpose of the Study:

  • To explore the application of network modeling in understanding endocrine resistance in breast cancer.
  • To illustrate computational modeling approaches using the unfolded protein response (UPR) pathway.

Main Methods:

  • Utilized differential dependency network analysis to identify network topologies.
  • Focused on the X-box binding protein 1 (XBP1) gene within the UPR network.
  • Computational modeling of gene dependencies and regulatory interactions.

Main Results:

  • Identified a subnetwork topology involving XBP1, BCAR3, BCL2, BIK, and NFκB.
  • Demonstrated the utility of network modeling in analyzing complex cellular signaling.
  • Highlighted the role of UPR activation in breast cancer cell fate.

Conclusions:

  • Network modeling provides a powerful approach to unraveling the complexities of endocrine resistance.
  • The identified XBP1 subnetwork offers a foundation for further mathematical modeling.
  • Future studies will integrate more data to build comprehensive models of the XBP1-UPR network.

Related Concept Videos

Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
Role of ER in the Secretory Pathway01:17

Role of ER in the Secretory Pathway

Eukaryotic cells have a special pathway that enables communication between various intracellular membrane-bound compartments and also with the extracellular environment. This pathway is termed as the secretory pathway.
Components of the secretory pathway
About a third of proteins synthesized in the cell are sorted via the secretory route. They shuffle between different compartments in membrane-bound vesicles until they reach their final destination. The main intracellular compartments involved...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Post-translational Translocation of Proteins to the RER01:27

Post-translational Translocation of Proteins to the RER

A sizable fraction of proteins destined for ER are first synthesized in the cell cytosol and then transported across the ER membrane–a process called post-translational translocation. Similar to cotranslationally translocated proteins, these proteins also use the Sec translocon complex to enter the ER lumen.
Targeting proteins to the ER
Hsp40 and Hsp70 chaperone molecules bind the translated proteins in the cytosol to prevent their folding. The chaperone binding helps to keep the signal...